- &series=261880
- &zsort=date
- 18
- 5000
- 20
- 1
Accession
|
Title
|
Sample type
|
Organism(s)
|
Ch
|
Platform
|
Series
|
Supplementary
|
Contact
|
Release date
|
Filter
|
|
|
|
|
|
GSE261880
|
|
|
|
GSM8153455
|
Control1
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153456
|
Control2
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153457
|
Control3
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153458
|
Erlotinib1
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153459
|
Erlotinib2
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153460
|
Erlotinib3
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153461
|
Erlotinib+PR1
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153462
|
Erlotinib+PR2
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153463
|
Erlotinib+PR3
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153464
|
Gefitinib1
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153465
|
Gefitinib2
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153466
|
Gefitinib3
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153467
|
Gefitinib+PR1
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153468
|
Gefitinib+PR2
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153469
|
Gefitinib+PR3
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153470
|
PR1
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153471
|
PR2
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|
GSM8153472
|
PR3
|
SRA
|
|
1 |
|
-
GSE261880
|
|
Haeseung Lee
|
Mar 24, 2024
|